Thrive score predicts outcomes with a third-generation endovascular stroke treatment device in the trevo-2 trial

Stroke

Volumn 44, Issue 12, 2013, Pages 3370-3375

  Flint, Alexander C ^a   Xiang, Bin ^a   Gupta, Rishi ^b   Nogueira, Raul G ^b   Lutsep, Helmi L ^c   Jovin, Tudor G ^d   Albers, Gregory W ^e   Liebeskind, David S ^f   Sanossian, Nerses ^g   Smith, Wade S ^h  

^a Kaiser Permanente ^*  (United States)

^b GRADY MEMORIAL HOSPITAL   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral hemorrhage; Forecasting; Outcome assessment; Stroke

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENDOVASCULAR STROKE TREATMENT DEVICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NON INVASIVE SURGICAL DEVICE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; STROKE PATIENT; THRIVE SCORE; TREATMENT OUTCOME; VALIDATION STUDY;

CEREBRAL HEMORRHAGE; FORECASTING; OUTCOME ASSESSMENT; STROKE;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COMBINED MODALITY THERAPY; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84889257463     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002796     Document Type: Article

References (17)

1. Hallevi H, Barreto AD, Liebeskind DS, Morales MM, Martin-Schild SB, Abraham AT, et al; UCLA Intra-Arterial Therapy Investigators. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke. 2009;40:1780-1785.
2. Flint AC, Cullen SP, Faigeles BS, Rao VA. Predicting long-term outcome after endovascular stroke treatment: the totaled health risks in vascular events score. AJNR Am J Neuroradiol. 2010;31:1192-1196.
3. Flint AC, Kamel H, Rao VA, Cullen SP, Faigeles BS, Smith WS. Validation of the Totaled Health Risks in Vascular Events (THRIVE) score for outcome prediction in endovascular stroke treatment. Int J Stroke. August 29, 2012. http://onlinelibrary.wiley.com/doi/10.1111/j.1747-4949.2012.00872.x/abstract. Accessed July 1, 2013.
4. Sarraj A. Optimizing prediction scores for poor outcome after intra-arterial therapy for anterior circulation acute ischemic stroke. International Stroke Conference, New Orleans, LA. Stroke. 2013:A205.
5. Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P. An integerbased score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology. 2012;78:1916-1922.
6. Strbian D, Meretoja A, Ahlhelm FJ, Pitkäniemi J, Lyrer P, Kaste M, et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology. 2012;78:427-432.
7. Saposnik G, Guzik AK, Reeves M, Ovbiagele B, Johnston SC. Stroke prognostication using age and NIH Stroke Scale: SPAN-100. Neurology. 2013;80:21-28.
8. Saposnik G, Fang J, Kapral MK, Tu JV, Mamdani M, Austin P, et al; Investigators of the Registry of the Canadian Stroke Network (RCSN); Stroke Outcomes Research Canada (SORCan) Working Group. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke. 2012;43:1315-1322.
9. Kamel H, Patel N, Rao VA, Cullen SP, Faigeles BS, Smith WS, et al. The THRIVE score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial. J Stroke Cerebrovasc Dis. November 2, 2012. http://www.strokejournal.org/article/S1052-3057(12)00311-4/abstract. Accessed July 1, 2013.
10. Flint AC, Faigeles BS, Cullen SP, Kamel H, Rao VA, Gupta R, et al. THRIVE Score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA. Stroke. 2013;44:3365-3369.
11. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380:1231-1240.
12. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241-1249.
13. Nilanont Y, Komoltri C, Saposnik G, Côté R, Di Legge S, Jin Y, et al. The Canadian Neurological Scale and the NIHSS: development and validation of a simple conversion model. Cerebrovasc Dis. 2010;30:120-126.
14. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al; DEFUSE 2 Study Investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860-867.
15. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914-923.
16. del Zoppo GJ. The neurovascular unit in the setting of stroke. J Intern Med. 2010;267:156-171.
17. Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, et al. AJNR Am J Neuroradiol. 2001;22:1534-1542